Vystar Corp (VYST)

[Boosted2gGSX]

Revenues for the three months ended September 30, 2019 and 2018 from the Company were $6,040,201 and $187,543, respectively, for an increase of $5,852,658 or 3,120.7%. The significant increase in revenues was due to an increase in operations as a whole due to multiple acquisitions since March 31, 2018.

 

The Company reported a significant increase in gross income to $2,661,981 for the three-month period ended September 30, 2019 compared to gross income of $4,606 for the three-month period ended September 30, 2018, an increase of $2,657,375. The cost of revenue for the three months ended September 30, 2019 and 2018 was $3,378,220 and $182,937, respectively, an increase of 1,746.7%. The increase is due to the greater inventory needs primarily from the acquisitions of Rotmans, UV Flu and NHS.

Right from the 10q